The South African Health Products Regulatory Authority, SAHPRA, says it has processed ten applications for the use of Ivermectin for the treatment of COVID-19. The body briefed Parliament's Portfolio Committee on Health on the use of the anti-parasitic drug. The CEO of SAHPRA, Boitumelo Semete, has so far repeated that there is insufficient data to approve that the drug for use in humans. The drug has been used elsewhere in the world to treat the virus, during small clinical trials. Earlier this week, lobby group, Afriforum, obtained an order from the High Court in Johannesburg that doctors may administer the drug in case of emergency, without waiting for the SAHRA's approval.
Guest: Dr Sibongiseni Dhlomo, Chairperson of the Portfolio Committee on Health